The hypothesis behind our research is based on the findings that an interaction between APP and Tau plays a role in the induction and/or progression of AD [7,8] and a disruption of this association may therapeutically prevent the cognitive ability deterioration seen in AD. The gene discussed is APP; the disease is Alzheimer disease.